Unit Dose Solutions, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 2405 Alwin Ct, Ste 100, Raleigh, North Carolina (NC) 27604, United States (USA)
- Operations here
- labelpackrelabelrepack
- FDA identifiers
- FEI 3005372033 · DUNS 360804194
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-05-27
- VAIDrug Quality Assurance2015-07-23
- VAIDrug Quality Assurance2011-12-19
Drugs this plant is listed as making
8 distinct drugs across 12 products name this site in their FDA label.
- AripiprazoleUnit Dose Solutions, Inc.
- Buprenorphine and NaloxoneUnit Dose Solutions, Inc.
- Buprenorphine Hydrochloride and Naloxone Hydrochloride DihydrateUnit Dose Solutions, Inc.
- CarbamazepineAtlantic Biologicals Corps
- CephalexinUnit Dose Solutions, Inc.
- Clindamycin hydrochlorideUnit Dose Solutions, Inc.
- Phentermine HydrochlorideMartek Pharmacal Co.
- TheophyllineBrandywine Pharmaceuticals, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.